BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 36881254)

  • 1. Treatment of Pediatric Low-Grade Gliomas.
    Sait SF; Giantini-Larsen AM; Tringale KR; Souweidane MM; Karajannis MA
    Curr Neurol Neurosci Rep; 2023 Apr; 23(4):185-199. PubMed ID: 36881254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
    van Tilburg CM; Kilburn LB; Perreault S; Schmidt R; Azizi AA; Cruz-Martínez O; Zápotocký M; Scheinemann K; Meeteren AYNS; Sehested A; Opocher E; Driever PH; Avula S; Ziegler DS; Capper D; Koch A; Sahm F; Qiu J; Tsao LP; Blackman SC; Manley P; Milde T; Witt R; Jones DTW; Hargrave D; Witt O
    BMC Cancer; 2024 Jan; 24(1):147. PubMed ID: 38291372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
    Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
    J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
    Fangusaro J; Jones DT; Packer RJ; Gutmann DH; Milde T; Witt O; Mueller S; Fisher MJ; Hansford JR; Tabori U; Hargrave D; Bandopadhayay P
    Neuro Oncol; 2024 Jan; 26(1):25-37. PubMed ID: 37944912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early experience with targeted therapy as a first-line adjuvant treatment for pediatric low-grade glioma.
    Leclair NK; Lambert W; Roche K; Gillan E; Gell JJ; Lau CC; Wrubel G; Knopf J; Amin S; Anderson M; Martin JE; Bookland MJ; Hersh DS
    Neurosurg Focus; 2022 Dec; 53(6):E15. PubMed ID: 36455272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
    Raabe E; Kieran MW; Cohen KJ
    Clin Cancer Res; 2013 Sep; 19(17):4553-8. PubMed ID: 23881924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pediatric low-grade glioma.
    de Blank P; Bandopadhayay P; Haas-Kogan D; Fouladi M; Fangusaro J
    Curr Opin Pediatr; 2019 Feb; 31(1):21-27. PubMed ID: 30531227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics and therapeutic targets of pediatric low-grade gliomas.
    Tateishi K; Nakamura T; Yamamoto T
    Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Molecular Update and Review of Current Trials in Paediatric Low-Grade Gliomas.
    Al-Jilaihawi S; Lowis S
    Pediatr Neurosurg; 2023; 58(5):290-298. PubMed ID: 37604126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
    Perreault S; Larouche V; Tabori U; Hawkin C; Lippé S; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; Sultan S; Cantin É; Routhier MÈ; Caru M; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Jabado N
    BMC Cancer; 2019 Dec; 19(1):1250. PubMed ID: 31881853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign Glioma.
    Wu PB; Filley AC; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity.
    Arnold A; Yuan M; Price A; Harris L; Eberhart CG; Raabe EH
    Neuro Oncol; 2020 Apr; 22(4):563-574. PubMed ID: 31841591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma.
    Rios JD; Velummailum R; Bennett J; Nobre L; Tsang DS; Bouffet E; Hawkins C; Tabori U; Denburg A; Pechlivanoglou P
    BMC Pediatr; 2022 Jan; 22(1):13. PubMed ID: 34980048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.
    Dasgupta T; Haas-Kogan DA
    Front Oncol; 2013; 3():110. PubMed ID: 23717811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in pediatric gliomas: from molecular characterization to personalized treatments.
    Sathyakumar S; Martinez M; Perreault S; Legault G; Bouffet E; Jabado N; Larouche V; Renzi S
    Eur J Pediatr; 2024 Jun; 183(6):2549-2562. PubMed ID: 38558313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.
    Fukuoka K; Mamatjan Y; Tatevossian R; Zapotocky M; Ryall S; Stucklin AG; Bennett J; Nobre LF; Arnoldo A; Luu B; Wen J; Zhu K; Leon A; Torti D; Pugh TJ; Hazrati LN; Laperriere N; Drake J; Rutka JT; Dirks P; Kulkarni AV; Taylor MD; Bartels U; Huang A; Zadeh G; Aldape K; Ramaswamy V; Bouffet E; Snuderl M; Ellison D; Hawkins C; Tabori U
    Neuro Oncol; 2020 Oct; 22(10):1474-1483. PubMed ID: 32242226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser interstitial thermal therapy (LITT) for pediatric low-grade glioma-case presentations and lessons learned.
    Strauss I; Gabay S; Roth J
    Childs Nerv Syst; 2024 May; ():. PubMed ID: 38703238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-guided laser interstitial thermal therapy for the treatment of low-grade gliomas in children: a case-series review, description of the current technologies and perspectives.
    Tovar-Spinoza Z; Choi H
    Childs Nerv Syst; 2016 Oct; 32(10):1947-56. PubMed ID: 27659837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.